{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:21:01Z","timestamp":1764174061535},"reference-count":36,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":573,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100003980","name":"Istituto Toscano Tumori","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003980","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009888","name":"Regione Toscana","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009888","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytometry"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1002\/cyto.b.21156","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T20:48:38Z","timestamp":1391633318000},"page":"340-349","source":"Crossref","is-referenced-by-count":7,"title":["CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia"],"prefix":"10.1002","volume":"86","author":[{"given":"Francesco","family":"Mannelli","sequence":"first","affiliation":[{"name":"UF di Ematologia, Dipartimento di Medicina Sperimentale e Clinica; Universit\u00e0 degli Studi, Firenze, and Istituto Toscano Tumori; Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Cutini","sequence":"additional","affiliation":[{"name":"UF di Ematologia, Dipartimento di Medicina Sperimentale e Clinica; Universit\u00e0 degli Studi, Firenze, and Istituto Toscano Tumori; Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Gianfaldoni","sequence":"additional","affiliation":[{"name":"UF di Ematologia, Dipartimento di Medicina Sperimentale e Clinica; Universit\u00e0 degli Studi, Firenze, and Istituto Toscano Tumori; Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Bencini","sequence":"additional","affiliation":[{"name":"UF di Ematologia, Dipartimento di Medicina Sperimentale e Clinica; Universit\u00e0 degli Studi, Firenze, and Istituto Toscano Tumori; Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Scappini","sequence":"additional","affiliation":[{"name":"UF di Ematologia, Dipartimento di Medicina Sperimentale e Clinica; Universit\u00e0 degli Studi, Firenze, and Istituto Toscano Tumori; Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Pancani","sequence":"additional","affiliation":[{"name":"UF di Ematologia, Dipartimento di Medicina Sperimentale e Clinica; Universit\u00e0 degli Studi, Firenze, and Istituto Toscano Tumori; Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Ponziani","sequence":"additional","affiliation":[{"name":"UF di Ematologia, Dipartimento di Medicina Sperimentale e Clinica; Universit\u00e0 degli Studi, Firenze, and Istituto Toscano Tumori; Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ida","family":"Bonetti","sequence":"additional","affiliation":[{"name":"UF di Ematologia, Dipartimento di Medicina Sperimentale e Clinica; Universit\u00e0 degli Studi, Firenze, and Istituto Toscano Tumori; Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Biagiotti","sequence":"additional","affiliation":[{"name":"UF di Ematologia, Dipartimento di Medicina Sperimentale e Clinica; Universit\u00e0 degli Studi, Firenze, and Istituto Toscano Tumori; Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Longo","sequence":"additional","affiliation":[{"name":"UF di Ematologia, Dipartimento di Medicina Sperimentale e Clinica; Universit\u00e0 degli Studi, Firenze, and Istituto Toscano Tumori; Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Bosi","sequence":"additional","affiliation":[{"name":"UF di Ematologia, Dipartimento di Medicina Sperimentale e Clinica; Universit\u00e0 degli Studi, Firenze, and Istituto Toscano Tumori; Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,2,5]]},"reference":[{"key":"10.1002\/cyto.b.21156-BIB0001|cytob21156-cit-0001","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: A new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"10.1002\/cyto.b.21156-BIB0002|cytob21156-cit-0002","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","article-title":"CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment","volume":"107","author":"Burger","year":"2006","journal-title":"Blood"},{"key":"10.1002\/cyto.b.21156-BIB0003|cytob21156-cit-0003","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/ncb1741","article-title":"A three-step pathway comprising PLZF\/miR-146a\/CXCR4 controls megakaryopoiesis","volume":"10","author":"Labbaye","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1002\/cyto.b.21156-BIB0004|cytob21156-cit-0004","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/cyto.b.21066","article-title":"The hematopoietic stem cell niche-home for friend and foe?","volume":"84B","author":"Krause","year":"2013","journal-title":"Cytometry B"},{"key":"10.1002\/cyto.b.21156-BIB0005|cytob21156-cit-0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cyto.b.21071","article-title":"New insights into the normal and leukemic stem cell niche: A timely review","volume":"84B","author":"Etten","year":"2013","journal-title":"Cytometry B"},{"key":"10.1002\/cyto.b.21156-BIB0006|cytob21156-cit-0006","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1158\/0008-5472.CAN-04-4406","article-title":"Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss of function induces expression of a ligand and its receptor","volume":"65","author":"Zagzag","year":"2005","journal-title":"Cancer Res"},{"key":"10.1002\/cyto.b.21156-BIB0007|cytob21156-cit-0007","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ccr.2004.09.027","article-title":"Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis","volume":"6","author":"Li","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1002\/cyto.b.21156-BIB0008|cytob21156-cit-0008","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.leu.2401602","article-title":"Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF1)","volume":"13","author":"Mohle","year":"1999","journal-title":"Leukemia"},{"key":"10.1002\/cyto.b.21156-BIB0009|cytob21156-cit-0009","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2141.2001.03164.x","article-title":"High expression of the chemokine receptor CXCR4 predicts extra-medullary organ infiltration in childhood acute lymphoblastic leukaemia","volume":"115","author":"Crazzolara","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1002\/cyto.b.21156-BIB0010|cytob21156-cit-0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1365-2141.2002.03835_6.x","article-title":"Is high expression of the chemokine receptor CXCR4 of predictive value for early relapse in childhood acute lymphoblastic leukaemia?","volume":"119","author":"Schneider","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1002\/cyto.b.21156-BIB0011|cytob21156-cit-0011","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2006-05-024844","article-title":"CXCR4 is a prognostic marker in acute myelogenous leukemia","volume":"109","author":"Spoo","year":"2007","journal-title":"Blood"},{"key":"10.1002\/cyto.b.21156-BIB0012|cytob21156-cit-0012","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1182\/blood-2004-02-0566","article-title":"Relation between CXCR4 expression, FLT3 mutations, and unfavorable prognosis of adult acute myeloid leukemia","volume":"104","author":"Rombouts","year":"2004","journal-title":"Blood"},{"key":"10.1002\/cyto.b.21156-BIB0013|cytob21156-cit-0013","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/cncr.22510","article-title":"Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype","volume":"109","author":"Konoplev","year":"2007","journal-title":"Cancer"},{"key":"10.1002\/cyto.b.21156-BIB0014|cytob21156-cit-0014","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the world health organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1002\/cyto.b.21156-BIB0015|cytob21156-cit-0015","article-title":"An International System for Human Cytogenetic Nomenclature","author":"Mitelman","year":"1995","journal-title":"Basel: S. Karger"},{"key":"10.1002\/cyto.b.21156-BIB0016|cytob21156-cit-0016","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: Determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"key":"10.1002\/cyto.b.21156-BIB0017|cytob21156-cit-0017","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood.V98.6.1752","article-title":"The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials","volume":"98","author":"Kottaridis","year":"2001","journal-title":"Blood"},{"key":"10.1002\/cyto.b.21156-BIB0018|cytob21156-cit-0018","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.leu.2403846","article-title":"Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia","volume":"19","author":"Noguera","year":"2005","journal-title":"Leukemia"},{"issue":"S1","key":"10.1002\/cyto.b.21156-BIB0019|cytob21156-cit-0019","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/cyto.b.20363","article-title":"2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia","volume":"72B","author":"Wood","year":"2007","journal-title":"Cytometry B"},{"key":"10.1002\/cyto.b.21156-BIB0020|cytob21156-cit-0020","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/sj.leu.2400847","article-title":"Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia","volume":"11","author":"Lacombe","year":"1997","journal-title":"Leukemia"},{"key":"10.1002\/cyto.b.21156-BIB0021|cytob21156-cit-0021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-1759(00)00226-X","article-title":"Validation and quality control of immunophenotyping in clinical flow cytometry","volume":"243","author":"Owens","year":"2000","journal-title":"J Immunol Methods"},{"key":"10.1002\/cyto.b.21156-BIB0022|cytob21156-cit-0022","first-page":"223","article-title":"Setting up and calibration of a flow cytometer for multicolorimmunophenotyping","volume":"17","author":"Kraan","year":"2003","journal-title":"J Biol Reg Homeos Ag"},{"key":"10.1002\/cyto.b.21156-BIB0023|cytob21156-cit-0023","first-page":"983","article-title":"Assessment of the normal or leukemic nature of CD34+ cells in acute myeloid leukemia with low percentages of CD34 cells","volume":"88","author":"der Pol","year":"2003","journal-title":"Haematologica"},{"key":"10.1002\/cyto.b.21156-BIB0024|cytob21156-cit-0024","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1182\/blood-2009-02-206565","article-title":"Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34- fraction","volume":"115","author":"Taussig","year":"2010","journal-title":"Blood"},{"key":"10.1002\/cyto.b.21156-BIB0025|cytob21156-cit-0025","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the International Working Group for diagnosis standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1002\/cyto.b.21156-BIB0026|cytob21156-cit-0026","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/blood.V66.6.1409.1409","article-title":"t(1;3)(p36;q21) in acute non-lymphocytic leukemia: A new cytogenetic-clinico pathologic association","volume":"66","author":"Bloomfield","year":"1985","journal-title":"Blood"},{"key":"10.1002\/cyto.b.21156-BIB0027|cytob21156-cit-0027","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2141.1993.tb04647.x","article-title":"Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the q arm of chromosome 3","volume":"83","author":"Grigg","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1002\/cyto.b.21156-BIB0028|cytob21156-cit-0028","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2141.2008.07428.x","article-title":"Dysregulation of stromal derived factor 1\/CXCR4 axis in the megakaryocytic lineage in essential thrombocythemia","volume":"144","author":"Salim","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1002\/cyto.b.21156-BIB0029|cytob21156-cit-0029","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2009-05-222331","article-title":"Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis","volume":"114","author":"Malcovati","year":"2009","journal-title":"Blood"},{"key":"10.1002\/cyto.b.21156-BIB0030|cytob21156-cit-0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nm.2054","article-title":"Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype","volume":"16","author":"Starczynowski","year":"2010","journal-title":"Nat Med"},{"key":"10.1002\/cyto.b.21156-BIB0031|cytob21156-cit-0031","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1038\/bcj.2011.24","article-title":"MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias","volume":"1","author":"Spinello","year":"2011","journal-title":"Blood Cancer J"},{"key":"10.1002\/cyto.b.21156-BIB0032|cytob21156-cit-0032","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yexmp.2010.11.009","article-title":"Nucleophosmin gene mutations promote NIH3T3 cell migration and invasion through CXCR4 and MMPs","volume":"90","author":"Shao","year":"2011","journal-title":"Exp Mol Pathol"},{"key":"10.1002\/cyto.b.21156-BIB0033|cytob21156-cit-0033","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1182\/blood-2005-05-2164","article-title":"Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: Interaction with other gene mutations","volume":"106","author":"Dohner","year":"2005","journal-title":"Blood"},{"key":"10.1002\/cyto.b.21156-BIB0034|cytob21156-cit-0034","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1200\/JCO.2010.28.3762","article-title":"IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication","volume":"28","author":"Paschka","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1002\/cyto.b.21156-BIB0035|cytob21156-cit-0035","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1002\/cyto.b.21156-BIB0036|cytob21156-cit-0036","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2011-10-383406","article-title":"A phase I\/II study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia","volume":"119","author":"Uy","year":"2012","journal-title":"Blood"}],"container-title":["Cytometry Part B: Clinical Cytometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcyto.b.21156","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T19:04:39Z","timestamp":1625252679000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cyto.b.21156"}},"subtitle":["Cxcr4 in Acute Myeloid Leukemia"],"short-title":[],"issued":{"date-parts":[[2014,2,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1002\/cyto.b.21156","relation":{},"ISSN":["1552-4949"],"issn-type":[{"value":"1552-4949","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,5]]}}}